Aushon Biosystems Thrives with Increasing Demand for Personalized Medicine
Wednesday, February 27, 2013
Adds former LabCorp leader Thomas Mac Mahon to board of directors, expects further growth in 2013.
Lab21 and IntegraGen Partner to Develop New Colorectal Cancer Diagnostic
Tuesday, February 26, 2013
Lab21 to develop a CE marked assay to detect expression levels of a microRNA biomarker.
ISPE Issues Global Drug Shortage Survey
Tuesday, February 26, 2013
Preliminary results are expected in June 2013.
Agilent Collaborating with Florida International University
Tuesday, February 26, 2013
Collaboration to further advance the identification and characterization of designer drugs.
Certain Mutations Affect Kidney Disease Risk and Prognosis
Monday, February 25, 2013
Screening could help in the diagnosis and treatment of affected individuals.
Gallo Center Scientists Identify Potential New Mechanism for Treating Problem Drinking
Monday, February 25, 2013
Researchers identified a potential new approach for reducing problem drinking: a new family of drugs with the ability to manipulate DNA structure without changing it.
Phenomenex Launches Innovative, Industry-Focused Websites
Friday, February 22, 2013
Company builds on award-winning web presence with new digital experience.
Companies Forge Huntington’s Disease Therapeutic and Companion Biomarker Collaboration
Friday, February 22, 2013
KineMed, Isis and CHDI collaborate to advance therapeutic development for Huntington’s disease and develop novel biomarkers for pre-clinical and clinical use in drug development and therapeutic monitoring.
CiToxLAB Group Increases Revenue by 25 Per Cent over Full Year of 2012
Thursday, February 21, 2013
Despite a stuttering outsourced preclinical development market, the global expansion of the CiToxLAB Group has attracted more clients.
|
|
|
|
|
|
